Clearmind Medicine files India patent for psychedelics

Clearmind Medicine has submitted a patent application in India for its next-generation psychedelic compounds, targeting the treatment of mental health disorders. This move signifies the company's commitment to expanding its intellectual property portfolio and exploring international markets for its innovative therapeutic candidates. The development aligns with a growing interest in psychedelic-assisted therapies for various psychological conditions. Clearmind's focus on developing novel treatments could position it as a key player in the evolving landscape of mental healthcare solutions.